Soleno Therapeutics Cash Flow Statement (2013-2026) | SLNO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-11.70M	-8.34M	-54.32M	-6.22M	-7.13M	-6.48M	-62.63M	-8.47M	-8.48M	-58.17M	-11.50M	-100.06M	-91.99M	-173.76M	-55.73M	-43.77M	-173.92M	-86.16M	43.49M	31.38M
Share-based Compensation (Quarter)	0.86M	0.91M	3.16M	0.64M	0.57M	0.68M	0.63M	0.63M	1.20M	2.20M	-4.04M	6.45M	7.16M	56.60M			9.70M	10.00M	11.47M	103.60M
Cash from Discontinued Operations (Quarter)
Gains from Investment Securities (Quarter)	-0.06M	-0.11M	-0.14M	-0.03M	-0.00M	-0.00M	0.00M		-0.00M	0.65M	-0.47M
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)	-8.01M	-5.41M	-6.86M	-6.36M	-4.62M	-4.66M	-5.14M	-6.73M	-5.57M	-6.33M	-6.31M	-12.53M	-17.65M	-14.93M	-23.99M	-32.75M	-12.65M	43.49M	48.71M	25.98M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)												0.47M	1.11M	1.91M	1.40M	0.98M	0.97M	0.37M	1.19M	0.22M
Amortization of Deferred Charges (Quarter)																0.01M	0.01M	0.01M	0.01M	0.01M
Depreciation & Amortization (CF) (Quarter)	0.49M	0.49M	0.49M	0.49M	0.49M	0.49M	0.49M	0.49M	0.49M	0.49M	0.49M	0.49M	0.49M	0.50M	0.50M	0.50M	0.50M	0.50M	0.51M	0.51M
Change in Working Capital
Change in Receivables (Quarter)																	24.62M	0.88M	2.70M	18.93M
Change in Inventory (Quarter)																	2.10M	3.92M	8.02M	1.83M
Change in Account Payables (Quarter)	-1.33M	-0.22M	0.13M	-1.05M	0.20M	-0.08M	-0.55M	1.00M	0.68M	-0.34M	0.03M	4.87M	-4.30M	2.53M	2.58M	-3.34M	0.73M	1.93M	4.29M	-2.97M
Change in Accured Expenses (Quarter)	-0.70M	0.16M	-0.17M	0.04M	0.06M	-0.69M	1.54M	0.21M	0.04M	0.02M	0.98M	-1.91M	0.92M	0.90M	-0.28M	-0.50M	3.93M	-0.96M	11.67M	-3.95M
Other Working Capital Changes (Quarter)	0.01M	0.12M	0.10M	-0.11M	-0.22M	-0.00M	0.22M	0.33M	-0.56M	0.40M	0.66M	-0.08M	-0.03M	-0.17M	1.03M	3.42M	-3.49M	-0.12M	4.93M	-0.78M
Investing Activities
Capital Expenditures (Quarter)		0.01M	0.01M				-0.01M					0.01M	0.01M	0.19M	0.01M		0.01M	0.00M	0.06M	0.00M
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)													25.00M	52.00M	54.00M	68.30M	51.50M	71.73M	62.54M	139.29M
Cash from Investing Activities (Quarter)		-0.01M	-0.01M				-0.01M					-115.24M	-120.92M	4.04M	6.44M	22.94M	-7.92M	-91.44M	-125.36M	37.98M
Financing Activities
Other financing activities (Quarter)				0.02M						8.40M	0.34M	0.01M	0.54M	0.77M	-0.00M	0.27M	13.72M	2.25M	0.95M	0.05M
Cash from Financing Activities (Quarter)	0.00M		-0.01M	14.03M	-0.28M	0.34M			17.06M	39.40M	123.56M	0.94M	152.75M	2.27M	57.06M	3.22M	15.69M	218.15M	-99.90M	-1.04M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)										-7.10M
Additional items
Change in Cash (Quarter)	-8.01M	-5.41M	-6.88M	7.67M	-4.91M	-1.21M	-8.26M	-6.73M	11.49M	33.07M	117.24M	-126.83M	14.18M	-8.61M	39.52M	-6.60M	-4.83M	170.16M	-176.56M	62.92M
Free Cash Flow (Quarter)	-8.01M	-5.41M	-6.88M	-6.36M	-4.62M	-4.66M	-5.14M	-6.73M	-5.57M	-6.33M	-6.31M	-12.54M	-17.66M	-15.12M	-24.00M	-32.75M	-12.66M	43.49M	48.65M	25.98M
Net Cash Flow (Quarter)	-8.01M	-5.41M	-6.88M	7.67M	-4.90M	-4.31M	-5.15M	-6.73M	11.49M	33.07M	117.24M	-126.83M	14.18M	-8.61M	39.52M	-6.60M	-4.87M	170.21M	-176.55M	62.92M

Research Tools

Developers

Soleno Therapeutics Cash Flow Statement (2013-2026) | SLNO

Research Tools

Developers

Soleno Therapeutics Cash Flow Statement (2013-2026) | SLNO

Create an account

Sign In

Reset Password